Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • November 05, 2026

    How Analytical Advances Reshape Biologic Patent Strategy

    As regulators shift away from relying on comparative clinical efficacy studies in biosimilar development, and more toward analytical data, practitioners should pay closer attention to post-translational modifications when evaluating patentability, says Gina Nellesen at Global Patent Group.

  • November 05, 2026

    Albertsons, Safeway Owe Wash. $900M Over Opioid Diversion

    Albertsons and its Safeway subsidiary must pay $900 million for helping fuel Washington state's overdose crisis by failing for years to prevent the diversion of opioid drugs, a Seattle judge ruled Thursday, finding that the pharmacy chains regularly failed to follow their own policies aimed at ensuring prescriptions were legitimate.

  • November 05, 2026

    Ropes & Gray-Led Pharma Biz Offers $541M For Swedish Rival

    U.S. biopharma company ANI said Thursday it has offered to acquire Swedish pharmaceutical company Egetis for up to approximately 5.3 billion Swedish kronor ($541 million) to gain access to a newly approved drug.

  • November 04, 2026

    Pharmacy Worker Says Dosage Machine Cut Off Fingertip

    A pharmacy worker suffered a "traumatic" finger amputation when a machine that dispenses liquid medication caught her index finger and ripped part of it off, according to a lawsuit in Pennsylvania state court that accuses medical device manufacturer Precision Products Group Inc. of defective design.

  • November 04, 2026

    Anti-Pot Group Eyes New Repeal Pushes After Mass. Loss

    After Election Day, anti-cannabis activists are pledging to bring repeal efforts to other states despite a decisive defeat in Massachusetts, while pro-cannabis industry and consumer-focused groups say they hope to work with a Democrat-controlled Congress to secure federal reform.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals